全球骶神經刺激市場研究報告-行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

骶神經刺激市場的全球需求預計將從2022年的22.8億美元成長到2030年的69.4億美元，2023-2030年的複合年成長率為14.9%。

骶神經刺激或骶神經調控是一種醫療程序，涉及使用電刺激來調節骶神經的活動。這些神經位於骶骨，負責控制膀胱、腸道和盆底肌肉。該療法主要用於治療保守療法無效的某些膀胱和腸道功能障礙。

市場動態：

膀胱和腸道功能障礙，如膀胱過度活動症（OAB）、尿瀦留和大便失禁，是影響很大一部分人口的普遍問題。這些疾病的發病率不斷上升，因此更需要有效的治療方案，包括骶神經刺激術。該療法為對保守療法無反應或不能耐受保守療法的患者提供了另一種選擇。全球人口老齡化導致膀胱和腸道功能障礙的發病率上升，從而引發了對骶神經刺激術等有效干涉措施的需求。體積更小、性能更先進的植入式神經刺激器的開發以及編程能力的增強擴大了市場潛力。該手術在緩解症狀、改善膀胱/腸道控制和提高患者生活品質方面取得了積極成果。隨著這些優點越來越為人所知並得到臨床證據的支持，患者和醫療服務提供者擴大將骶神經刺激作為一種治療選擇。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構，評估全球範圍內的競爭吸引力。此外，這些工具還對全球骶神經刺激市場的各個細分市場進行了全面評估。骶神經刺激器行業的成長和趨勢為本研究提供了整體方法。

市場細分：

骶神經刺激器市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按產品分類

• 植入式
• 外用

按應用

• 大小便失禁
• 急迫性尿失禁
• 慢性肛裂
• 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲骶神經刺激市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。骶神經刺激市場的主要參與者包括Medtronic PLC、Axonics Modulation Technologies, Inc.、Nuvectra和Cogentix Medical。本節對競爭格局進行了整體分析，包括各種戰略發展，如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品上市及其他發展。

目 錄

第一章：前言

• 報告描述
  • 報告目標
  • 目標受眾
  • 獨特銷售主張（USP）和產品
• 研究範圍
• 研究方法
  • 市場調研流程
  • 市場調研方法

第二章：執行摘要

• 市場亮點
• 全球市場概況

第三章：骶神經刺激-行業分析

• 簡介- 市場動態
• 市場驅動因素
• 市場限制因素
• 市場機會
• 行業趨勢
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 市場吸引力分析：按應用
  • 市場吸引力分析：按地區

第四章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料製造商列表
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直接行銷
  • 間接行銷
  • 行銷管道發展趨勢

第五章：全球骶神經刺激器市場分析：按產品分類

• 產品概述
• 歷史和預測數據
• 按產品分析
• 植入式
• 外置式

第六章：全球骶神經刺激市場分析：按應用分類

• 概述：按應用
• 歷史和預測數據
• 分析：按應用
• 大小便失禁
• 急迫性尿失禁
• 慢性肛裂
• 其他

第七章：全球骶神經刺激市場分析：按地理區域分類

• 地區展望
• 產品介紹
• 北美銷售分析
  • 概述、歷史和預測數據銷售分析
  • 北美地區銷售分析
  • 北美各國銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 歐洲銷售分析
  • 歐洲各國銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測數據銷售分析
  • 亞太地區細分市場銷售分析
  • 亞太地區各國銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 拉丁美洲各細分市場銷售分析
  • 拉丁美洲各國銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 中東及非洲地區銷售分析
  • 中東及非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東及非洲其他地區銷售分析

第八章: 骶神經刺激器企業競爭格局

• 骶神經刺激器市場競爭格局
• 夥伴關係/合作/協議
• 合併與收購
• 新產品發布
• 其他發展

第九章: 公司簡介

• 頂級公司市場佔有率分析
• 市場集中度
• Medtronic PLC
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Axonics Modulation Technologies Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Nuvectra
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Cogentix Medical
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

The global demand for Sacral Nerve Stimulation Market is presumed to reach the market size of nearly USD 6.94 BN by 2030 from USD 2.28 BN in 2022 with a CAGR of 14.9% under the study period 2023 - 2030.

Sacral nerve stimulation, or sacral neuromodulation, is a medical procedure that involves the use of electrical stimulation to modulate the activity of the sacral nerves. These nerves are located in the sacrum and are responsible for controlling the bladder, bowel, and pelvic floor muscles. This procedure is primarily used to treat certain bladder and bowel dysfunctions that have not responded to conservative treatments.

Market Dynamics:

Bladder and bowel dysfunctions, such as overactive bladder (OAB), urinary retention, and faecal incontinence, are prevalent issues affecting a significant portion of the population. The rising incidence of these conditions creates a greater need for effective treatment options, including sacral nerve stimulation. This process offers an alternative for individuals who have not responded to or cannot tolerate conservative therapies. The global population is ageing, leading to an increased prevalence of bladder and bowel dysfunctions, thereby leading to the demand for effective interventions such as sacral nerve stimulation. The development of smaller, more advanced implantable neurostimulators and enhanced programming capabilities have expanded the market potential. This procedure has demonstrated positive outcomes in terms of symptom relief, improved bladder/bowel control, and enhanced quality of life for patients. As these benefits become more well-known and supported by clinical evidence, both patients and healthcare providers are increasingly seeking sacral nerve stimulation as a treatment option.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of sacral nerve stimulation. The growth and trends of sacral nerve stimulation industry provide a holistic approach to this study.

Market Segmentation:

This section of the sacral nerve stimulation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Implantable
• External

By Application

• Urinary & Fecal Incontinence
• Urge Incontinence
• Chronic Anal Fissure
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Sacral Nerve Stimulation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the sacral nerve stimulation market include Medtronic PLC; Axonics Modulation Technologies, Inc.; Nuvectra; Cogentix Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . SACRAL NERVE STIMULATION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SACRAL NERVE STIMULATION MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Implantable Historic and Forecast Sales by Regions
• 5.5 External Historic and Forecast Sales by Regions

6 . GLOBAL SACRAL NERVE STIMULATION MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Urinary & Fecal Incontinence Historic and Forecast Sales by Regions
• 6.5 Urge Incontinence Historic and Forecast Sales by Regions
• 6.6 Chronic Anal Fissure Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL SACRAL NERVE STIMULATION MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE SACRAL NERVE STIMULATION COMPANIES

• 8.1. Sacral Nerve Stimulation Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF SACRAL NERVE STIMULATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Medtronic PLC
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Axonics Modulation Technologies Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Nuvectra
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Cogentix Medical
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Implantable Market Sales by Geography (USD MN)
• External Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Urinary & Fecal Incontinence Market Sales by Geography (USD MN)
• Urge Incontinence Market Sales by Geography (USD MN)
• Chronic Anal Fissure Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Sacral Nerve Stimulation Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Sacral Nerve Stimulation Report
• Market Research Process
• Market Research Methodology
• Global Sacral Nerve Stimulation Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Implantable Market Sales by Geography (USD MN)
• External Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Urinary & Fecal Incontinence Market Sales by Geography (USD MN)
• Urge Incontinence Market Sales by Geography (USD MN)
• Chronic Anal Fissure Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.